Global Genetic Testing Market Report 2020-2024: What Key Interest is Driving Direct to Consumer?
Dublin, Oct. 13, 2020 (GLOBE NEWSWIRE) -- The "The Global Genetic Testing Market by Hereditary, Newborn, NIPT, Oncology, Pharmacogenomic and Direct to Consumer, With Executive and Consultant Guides 2020 to 2024" report has been added to ResearchAndMarkets.com's offering.
Will all newborns receive Whole Genomic Sequencing at birth? What key interest is driving Direct to Consumer?
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2024. The report includes detailed breakouts for 14 countries and 5 regions.
Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
Key Topics Covered:
1. Introduction and Market Definition
1.1 Genetic Testing Definition in This Report
1.2 The Genomics Revolution
1.3 Market Definition
1.3.1 Revenue Market Size
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for Laboratory Testing
2. Market Overview
2.1 Market Participants Play Different Roles
2.1.1 Supplier/pharmaceutical
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 DTC Lab
2.1.9 Independent Genetic Testing Lab
2.1.10 Audit Body
2.2 Genetic Tests -Types, Examples and Discussion
2.2.1 Preimplantation Genetic Diagnosis- An Emerging Market
2.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
2.2.3 Newborn Screening
2.2.2 Diagnostic Testing
2.2.3 Carrier Testing
2.2.6 Predictive and Presymptomatic Testing
2.2.7 Pharmacogenomics
2.2.8 Forensic Testing
2.2.9 Parental Testing
2.2.10 Ancestral Testing
2.3 Industry Structure
2.3.1 Hospital's Testing Share
2.3.2 Economies of Scale
2.3.2.1 Hospital vs. Central Lab
2.3.3 Physician Office Lab's
2.3.4 Physician's and POCT
2.4 Market Shares of Key Genetics Players - Analysis
3. Market Trends
3.1 Factors Driving Growth
3.1.1 Genetic Discoveries Creating New Diagnostic Markets
3.1.2 Aging Population a Boon for Diagnostics
3.1.3 Pharmacogenomics Drives Further Growth
3.1.4 Oncology and Liquid Biopsy Enter New Era
3.1.5 Fertility Practice Growth drives market
3.1.6 Direct to Consumer begins to break out
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers Price
3.2.2 Lower Costs
3.2.3 Testing usage analysis curtailing growth
3.2.4 Wellness has a downside
3.3 Instrumentation and Automation
3.3.1 Instruments Key to Market Share
3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.1 Next Generation Sequencing Fuels a Revolution
3.4.2 Impact of NGS on pricing
3.4.3 POCT/Self Testing Disruptive Force
3.4.4 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.5 CGES Testing, A Brave New World
3.4.6 Biochips/Giant magnetoresistance based assay
4. Genetic Testing Recent Developments
4.1.1 Importance of This Section
4.1.2 How to Use This Section
Blueprint Genetics, Archimedlife to Launch Genetic Testing in North America
Invitae to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
Phosphorus Offers DNA Testing to Assess Disease Risk
Arivale Shuts Down Personalized Wellness Business
ArcherDX Acquires Baby Genes
MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay
Thermo Fisher Purchases 9 Percent Stake in Yourgene Health
Invitae Partners to Expand Free Epilepsy Genetic Testing Program
Illumina, Chinese Firm Partner on NGS System for Genetic Disease Dx
NanoString Technologies Prices $103.5M Common Stock Offering
Canine Consumer Genomics Firm Embark Veterinary Raises $10M
Yourgene Health to Acquire Elucigene
Helix, AdventHealth Partner on Genetic Screening Study
Qiagen, NeuMoDx Ink Partnership, Merger Agreement
Prenetics Acquires DNAFit for $10M
Myriad Genetics to Acquire Counsyl for $375M
Roche inks $2.4B deal to buy out Foundation Medicine
Rapid genome sequencing could revolutionize health care
Scientists discover new nanoparticle, dubbed exomeres, released by tumours
New DNA tests look for 190 diseases in newborn's genetic code
Cordlife, PlumCare Partner to Offer Genetic Testing Services in Asia
New genetic risk score could help guide screening decisions for prostate cancer
Tele-genetics pilot makes genetic counselling accessible
Digital Genetic Assistant OptraGURUT Launches Today from Optra Health
PacBridge Capital Partners Invests C$12M in Contextual Genomics
From DNA To Disease: A Diagnosis Made In Under A Day
5. Profiles of Key Companies
10x Genomics, Inc
23andME Inc
Abbott Diagnostics
AccuraGen Inc
Adaptive Biotechnologies
Admera Health, LLC
Agena Bioscience, Inc
Agilent
Akonni Biosystems
Ancestry.com LLC
Anchor Dx
ArcherDx, Inc
ARUP Laboratories
Asuragen
Baylor Miraca Genetics Laboratories
Beckman Coulter, Inc
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bioarray Genetics
Biocept, Inc
Biodesix Inc
BioFluidica
BioGenex
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
Bio-Techne
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Centogene
Chronix Biomedical
Circulogene
Clinical Genomics
Color Genomics
Complete Genomics, Inc. - A BGI Company
Cynvenio
Dante Labs
Datar Cancer Genetics Limited
Diasorin S.p.A
Epic Sciences
Epigenomics AG
Eurofins Scientific
Excellerate Bioscience
Exosome Diagnostics
Fabric Genomics
Fluidigm Corp
Foundation Medicine
Freenome
FUJIFILM Wako Diagnostics
Fujirebio
GE Global Research
GE Healthcare Life Sciences
Gene by Gene, Ltd
Genedrive
GeneFirst Ltd
Genetron Health (Beijing) Co., Ltd
Genewiz
Genomic Health
Genomics England
Genomics Personalized Health (GPH)
GenomOncology
Genzyme Corporation
Grail, Inc
Grifols
Guardant Health
Guardiome
HeiScreen
Helix
Helomics
Hologic
Horizon Discovery
HTG Molecular Diagnostics
Human Longevity, Inc
iCellate
Illumina
Incell Dx
Inivata
Integrated Diagnostics
Invitae Corporation
Invivoscribe
Karius
Macrogen
MDNA Life SCIENCES, Inc
MDx Health
Medgenome
Meridian Bioscience
Mesa Biotech
MIODx
miR Scientific
MNG Labs
Molecular MD
NantHealth, Inc
Natera
Nebula Genomics
NeoGenomics
New Oncology
Novogene Bioinformatics Technology Co., Ltd
Omega Bioservices
OncoDNA
ORIG3N, Inc
Origene Technologies
Oxford Nanopore Technologies
Pacific Biosciences
Panagene
Perkin Elmer
Personal Genome Diagnostics
Personalis
Precipio
PrecisionMed
Promega
Protagen Diagnostics
Qiagen Gmbh
Quantumdx
Regeneron
Roche Molecular Diagnostics
Roswell Biotechnologies
Seegene
Sequencing.com
Siemens Healthineers
simfo GmbH
Singlera Genomics Inc
SkylineDx
Stratos Genomics
Sure Genomics, Inc
Sysmex
Sysmex Inostics
Tempus Labs, Inc
Thermo Fisher Scientific Inc
Veritas Genetics
Volition
6. Global Market Size
6.1 Global Market by Country
6.2 Global Market by Application
7. Market Sizes by Application
7.1 Hereditary Testing Market
7.2 Newborn Testing Market
7.3 NIPT Testing Market
7.4 Oncology Testing Market
7.5 Pharmacogenomic Testing Market
7.6 Direct to Consumer Testing Market
8. The Future of Genetic Testing
For more information about this report visit https://www.researchandmarkets.com/r/lx24wn
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900